Financials
- Market Capitalization 305.89 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG011J3QM39
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.25
市销率
11.26
每股股息
—
股息收益率 %
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3316 | IRD Opus Genetics, Inc. - Common Stock | 3.81 USD | -2.81% | -7.30% | -7.52% | +2.42% | 310.12 M USD | ||
| 3319 | EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -3.07% | -13.42% | +24.90% | +9.72% | 309.38 M USD | ||
| 3337 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.22 USD | -4.69% | -8.96% | -6.15% | -28.95% | 304.14 M USD | ||
| 3340 | GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | +13.30% | 0.00% | +71.64% | +56.46% | 302.94 M USD |